CMC(SH:600327) Sou Hu Cai Jing·2025-06-18 10:27Group 1 - The core viewpoint of the articles highlights the financial performance and market position of the company, Da Dongfang, within the medical services industry [1][2] - As of June 18, the company's closing stock price was 4.65 yuan, reflecting a decrease of 1.90%, with a rolling price-to-earnings (PE) ratio of 67.28 times, and a total market capitalization of 4.114 billion yuan [1] - The average PE ratio for the medical services industry is 39.59 times, with a median of 43.15 times, positioning Da Dongfang at 35th place within the industry rankings [1][2] Group 2 - For the first quarter of 2025, Da Dongfang reported a revenue of 921 million yuan, representing a year-on-year decrease of 8.55%, while net profit was 39.932 million yuan, showing a significant year-on-year increase of 78.14%, with a sales gross margin of 19.46% [1] - The company is primarily engaged in department store retail, Sanfengqiao brand operations, and healthcare services, and has received various accolades, including being listed among the "Top 500 Private Enterprises in China" and "Top 100 Private Service Enterprises in China" [1]